News

Are you a squeezed dermatologist? I am afraid many of us are entering this uncomfortable position with little space for relief.

A variety of treatments aside from antibiotics have shown some efficacy in managing hidradenitis suppurativa (HS), according to a clinician speaking at the Dermatology Update 2013 meeting.

Dr. Doe has a 25-year-old dermatology practice in a quiet suburban area. Although he loves practicing dermatology, he finds himself overwhelmed with government regulation. HIPAA, EMR, meaningful use, ACA - he does not know where to begin.

There is a suggestion that early treatment of severe psoriasis will decrease the risk of cardiovascular comorbidities that have been associated with severe psoriasis such as stroke and heart attack, according to a clinical professor dermatology at the State University of New York Buffalo School of Medicine.

Successful laser treatment of pigmented lesions and tattoos requires choosing the right tool for the job, an expert says.

To document the value of melanoma screening, researchers in the United States continue to refine screening strategies, an expert says.

Treatment for metastatic melanoma has begun a dramatic renaissance with the development of novel immunotherapy strategies and targeted therapeutic approaches.

The commercialization of ingenol mebutate (Picato, LEO Pharma) a medication that is currently approved in the United States and many other countries for the treatment of actinic keratosis, is an example of how enthusiasm and commitment can drive innovation, a LEO Pharma general manager says.

A new area of research may help in the development of more effective topical products to counteract polycyclic aromatic hydrocarbons, a result of air pollution which impacts skin aging.

Key concerns regarding infectious diseases with cutaneous manifestations include the expanding reach of infections formerly thought rare and exotic, experts say. Meanwhile, they add, some infections rarely seen stateside in recent years are resurging.

Cosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.

Are you interested in learning how to promote your dermatology practice on Twitter? Compared to other social networks, Twitter is one of the simplest and most straightforward platforms you could ever use.

Purpura, whether after trauma or an aesthetic procedure, is undesirable to patients. The ecchymoses can last for up to two weeks, and dyspigmentation can persist even longer.

Kent Remington, M.D., guides patients through his method for conducting a successful aesthetic consult, he told attendees at the MauiDerm 2014 meeting. Knowing a patient’s “real” reasons for aesthetic improvement - and shifting from a monotherapy toward performing a full-face rejuvenation following a multitherapeutic approach - are essential in achieving excellent aesthetic outcomes, he told attendees at the MauiDerm 2014 meeting.

We’re learning more about the aging process and how it occurs at different levels: from the surface of the skin, all the way down to the bony structure. Our purpose in aesthetics is to understand this process and to work with it to highlight the natural beauty of an individual, Ava Shamban, M.D., told attendees at the MauiDerm 2014 meeting.

Couldn't make it to MauiDerm 2014? Here is a brief collection of some of the poster presentations from the conference.

Michael Gold, M.D., at the MauiDerm 2014 conference shared his insight into the world of fake botulinum toxins. There is a huge counterfeit market, and it behooves dermatologists to be aware, because the products are easily acquired over the Internet or purchased overseas and carried into the United States.

Joel Cohen, M.D., explained to attendees at MauiDerm 2014 the differences among the three approved botulinum toxin products and how to use them successfully to take advantage of their unique properties. He recommended that doctors really think about these products as unique and begin to use them for their individual properties.

New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.

A multispectral digital skin lesion analysis device may be useful in helping clinicians to classify clinically ambiguous lesions, detect early melanomas in young adults, and identify outlier lesions that should be biopsied, according to a collection of posters presented at MauiDerm 2014.

At the MauiDerm 2014 meeting, conference organizer George Martin, M.D., shared five clinical pearls for treating facial actinic keratosis (AK).

Nutraceuticals and the claims that these products make have become increasingly popular on a global basis, according to an expert who spoke at MauiDerm 2014.

Dermatologists report high job satisfaction and are among the most likely of all specialties to take dietary supplements, a recent report suggests.

Topical hydration can reduce thermal damage to skin treated with a plasma skin regeneration (PSR) device, according to a recent study.

Results of a new study show that laser and other light-based therapies show potential as a treatment for onychomycosis.

The MauiDerm 2014 meeting kicked off Sunday with a Hawaiian blessing led by the conference's organizer, George Martin, M.D., Dermatology and Laser Center of Maui, Kihei, Hawaii.

In an effort to learn more about patients’ experiences with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome, researchers have developed two new questionnaires to evaluate and assess the effects of the diseases.

The Food and Drug Administration has approved GlaxoSmithKline’s Mekinist (trametinib) for use in combination with Tafinlar (dabrafenib) as a possible treatment for patients suffering from inoperable melanoma and certain types of metastatic melanoma.

Valeant Pharmaceuticals has partnered with a beauty company to create aesthetic products, beginning with a technology that reshapes the appearance of the skin.

Dermoscopy can be a useful and reliable tool to differentiate between superficial basal cell carcinoma and other basal cell carcinoma subtypes, according to a recent study.